Main Article Content


Guillain-Barré-Syndrome (GBS) is one of the reported neurological manifestations linked to a severe acute respiratory syndrome caused by coronavirus 2 (SARS-CoV-2)(COVID-19). We are presenting a case of a 72-years-old male patient who attended Sultan Qaboos University Hospital with a history of progressive bilateral limbs weakness and numbness. After exclusion of other possible causes, a diagnosis of GBS induced by COVID-19 was made. He received Intravenous Immunoglobulin (IVIG) 0.4g/kg/day for 5 days.  This diagnosis is in line with a rare complication of COVID-19. This case highlights the characteristics and the course of GBS following COVID-19 infection. Further studies are needed to characterize the manifestations and the course of various neuromuscular disorders in relation to COVID-19 infection.

Keywords: COVID-19, Guillain-Barré-Syndrome (GBS), IVIG, Oman

Article Details

How to Cite
Al-Zadjali, M. M., Al Shibli, E., Al Maskari, M., Gujjar, A. R., & Al Asmi, A. (2022). Post COVID-19 Guillain-Barré-Syndrome (GBS): A case report from Oman. Sultan Qaboos University Medical Journal, 22(3), 409–412.

Most read articles by the same author(s)